The National Task force for COVID-19, constituted by Indian Council of Medical Research, recommended the use of hydroxychloroquine as prophylaxis (preventive drug) of SARS-COV-2 infection for high risk population on 23 March.
The following high-risk population can be put under chemoprophylaxis with hydroxychloroquine:
• Asymptomatic Healthcare Workers involved in the care of suspected or confirmed cases of COVID
• Asymptomatic household contacts of laboratory confirmed cases
In the United States, President Donald Trump hailed the drug as something that could counter coronavirus, but health experts have expressed reservations ever since.
In this video, we try to gather the basics of what we know about the drug and its possible use in the future.